Absci Corporation share price logo

Absci Corporation

NASDAQ: ABSI

Small Cap

$7.41

+0.23

(+3.20%)

as on

Absci Corporation Stock Performance

as on June 19, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $7.11
    $7.55
    downward going graph

    4.05%

    Downside

    1.89%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.24
    $8.17
    downward going graph

    69.77%

    Downside

    10.26%

    Upside

    downward going graph

Absci Corporation share price movements today

Previous Close
$7.18
Open
$7.42
Volume
8.1M
Day's Low - High
$7.11 - $7.55
52 Week Low - High
$2.24 - $8.17

Absci Corporation Historical Returns

1 Month Return
+ 60.04 %
3 Month Return
+ 140.58 %
1 Year Return
+ 169.45 %
3 Year Return
+ 323.43 %
5 Year Return
0 %

Absci Corporation Stock Fundamentals & Key Indicators

Check Absci Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.2B

EPS (TTM)

-0.772

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-116.4M

Revenue (TTM)

1.8M

Profit Margin

0.00%

Return On Equity TTM

-63.89%

Absci Corporation vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Absci Corporation with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$1.2BNANA0.00%NA
BUY$37.7B57.21%71.2112.55%NA
BUY$116.5B140.42%27.2235.51%NA
BUY$63.7B13.39%14.8529.65%0.58%

Stock Returns calculator for Absci Corporation Stock including INR - Dollar returns

The Absci Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Absci Corporation investment value today

Current value as on today

₹2,93,512

Returns

₹1,93,512

(+193.51%)

Returns from Absci Corporation Stock

₹1,69,455 (+169.45%)

Dollar Impact

₹24,057 (+24.06%)

Analyst Recommendation on Absci Corporation Stock

Based on 12 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for Absci Corporation. Average target price of $9.61

Absci Corporation Share Price Target

Get share price movements and forecasts by analysts on Absci Corporation.

What analysts predicted

22.89%UPSIDE

Target Price

$9.61

Current Price

$7.41

Analyzed by

12 Analysts

Target

$9.61

Absci Corporation target price $9.61, a slight upside of 22.89% compared to current price of $7.41. According to 12 analysts rating.

Indian Investors' Interest in Absci Corporation Stock

Search interest for Absci Corporation Stock has increased by 116% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:116% versus previous 30 day period

Absci Corporation Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
0
0
1
1
0
1
0
0
0
0
Gross Profit
-11
-11
-13
-1
-16
-15
-19
0
-2
-2
Operating Income
-24
-23
-26
-28
-29
-27
-31
-30
-36
-30
EBITDA
-20
-18
-21
-23
-25
-23
-27
-25
-26
-26
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
3
3
3
3
3
3
3
2
2
2
Income Before Tax
-23
-21
-24
-27
-28
-26
-30
-28
-29
-29
Income Tax Expense
0
0
24
0
0
0
0
0
0
0
Net Income
-23
-21
-24
-27
-28
-26
-30
-28
-29
-29
Net Profit Margin
-6965.98%
-2447.10%
-1948.82%
-1610.70%
-4358.35%
-2234.61%
-5154.97%
-7594.18%
-4548.00%
-13766.98%

Absci Corporation Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
2
4
4
5
5
4
2
Gross Profit
2
-6
-39
-53
-41
-57
-8
Operating Income
-6
-13
-75
-106
-115
-108
-124
EBITDA
-5
-12
-67
-91
-79
-94
-103
Interest Expense
0
0
3
0
1
0
0
Depreciation
0
1
6
13
14
13
11
Income Before Tax
-6
-14
-109
-105
-110
-103
-115
Income Tax Expense
0
0
-8
0
0
0
0
Net Income
-6
-14
-100
-104
-110
-103
-115
Net Profit Margin
-319.61%
-300.27%
-2111.25%
-1825.37%
-1933.65%
-2274.06%
-4113.68%

Absci Corporation Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-21
-24
-27
-28
-26
-30
-28
-29
-29
Operating Cash Flow
-17
-16
-20
-16
-21
-16
-25
-29
-26
Investing Cash Flow
-76
1
14
19
-15
9
-63
19
7
Financing Cash Flow
81
0
0
0
42
-1
60
3
7
Change in Cash
-13
-15
-5
3
5
-8
-28
-5
-11

Absci Corporation Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-14
-100
-104
-110
-103
-115
Operating Cash Flow
-10
-60
-81
-64
-72
-92
Investing Cash Flow
-2
-67
-126
81
-41
-50
Financing Cash Flow
70
336
5
-4
82
105
Change in Cash
57
208
-203
12
-31
-37

Global Institutional Holdings in Absci Corporation

Funds
Holdings
Geode Capital Management, LLC
2.15%
Bank of America Corp
1.25%
Ameriprise Financial Inc
2.05%
Baker Bros Advisors LP
1.37%
Amova Asset Management Americas, Inc
0.87%

Absci Corporation News & Key Events

  • img

    Today's Timeline - 11 September

    Thu, 09:30 PM

    -

    Absci collaborates with Oracle and AMD to enhance its generative AI Drug Creation Platform, accelerating drug discovery processes.

Insights on Absci Corporation

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ABSI has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ABSI has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, ABSI stock has moved up by 9.0%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 650.0K → 215.0K (in $), with an average decrease of 66.9% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -28.70M → -29.59M (in $), with an average decrease of 1.6% per quarter

About Absci Corporation

Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.
OrganisationAbsci Corporation
Headquarters18105 SE Mill Plain Boulevard, Vancouver, WA, United States, 98683
IndustryBiotechnology
CEOMr. Sean McClain
E-voting on sharesClick here to vote

Key Management of Absci Corporation

Name

Title

Ms. Jeanne Schreuder M.B.A., SPHR

Senior Vice President of People & Experience

Mr. Wen Sha

Chief of Staff

Dr. Christine Lemke D.V.M., M.B.A., Ph.D.

Senior Vice President of Portfolio & Growth Strategy

Mr. Amer-Denis Akkad Ph.D.

Vice President of Research

Dr. Zachariah Jonasson Ph.D.

Chief Business Officer & CFO

Mr. Todd Bedrick CPA

Senior VP & Chief Accounting Officer

Mr. Alexander Khan CPA

CVP of Finance & Head of Investor Relations

Mr. Sean McClain

Founder, CEO, President & Director

Ms. Shelby Walker J.D.

Chief Legal Officer

Dr. Ransi Somaratne FACC, M.B.A., M.D.

Chief Medical Officer

FAQs

What is Absci Corporation share price today?

Absci Corporation share price today is $7.41 as on at the close of the market. Absci Corporation share today touched a day high of $7.55 and a low of $7.11.

What is the 52 week high and 52 week low for Absci Corporation share?

Absci Corporation share touched a 52 week high of $8.17 on and a 52 week low of $2.24 on . Absci Corporation stock price today i.e. is closed at $7.41,which is 9.30% down from its 52 week high and 230.80% up from its 52 week low.

What is Absci Corporation's market capitalisation today?

Absci Corporation market capitalisation is $0.00T as on .

How to invest in Absci Corporation Stock (ABSI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Absci Corporation on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Absci Corporation Shares that will get you 0.2024 shares as per Absci Corporation share price of $7.41 per share as on June 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Absci Corporation Stock (ABSI) from India?

Indian investors can start investing in Absci Corporation (ABSI) shares with as little as ₹94.31 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in Absci Corporation stock (as per the Rupee-Dollar exchange rate as on ). Based on Absci Corporation share’s latest price of $7.41 as on June 19, 2026 at 8:45 am IST, you will get 1.3495 shares of Absci Corporation. Learn more about fractional shares .